Medical Science Liaison

Sobi offers the opportunity to work at an international pharmaceutical company focused on specialty pharmaceuticals meeting the high medical needs of rare disease patients and providing treatment and services to them. Our employees come from a variety of backgrounds within research, healthcare, industry and the academic sphere.

Purpose of Role

• Develop the science and understanding of the relevant rare and ultra-rare disease states
• Representing Sobi in supporting the quality use of medicines and favourable patient outcomes
• Contributing to the successful working model for Sobi based on partnerships, credibility, agility and scientific expertise
• Field-based medical professional joining an experienced team in growing the Australian affiliate
• Build awareness of Sobi clinical data, provide education on existing and pipeline therapies, company profile, and to sustain professional relationships with a network of key opinion leaders in haematology and immunology
• Developing and delivering medical education initiatives
• Building and strengthening a network of partnerships with KOLs in haematology and immunology
• Contribute to strategic planning, and execution of medical field activities and initiatives, as well as evidence generation plan development.
• Provide field support and insights across the Sobi franchise and growing pipeline
• Sydney based with responsibility for VIC/TAS, SA, WA.

The purpose of this field-based position is to provide non-promotional educational, scientific and research support for the Sobi rare disease portfolio. The MSL will develop and maintain professional relationships with some of the country’s leading opinion leaders in scope of Sobi programs in the immunology and haematology franchise and pro-actively drive the local medical plan in accordance with local laws and the Medicines Australia Code of Conduct. In addition, the MSL/SMSL will serve as strong advocate for patients by striving to increase awareness of medical and patient needs, understanding of data gaps and potential means address, and to support timely access to therapies.

Essential Responsibilities

Including, but not limited to the following:

• Develop and communicate in-depth scientific knowledge of the rare disorders of interest to Sobi, including: Paroxysmal nocturnal haemoglobinuria (PNH), Immune Thrombocytopenia (ITP), primary HLH, CAPS, DLBCL, and myelofibrosis.
• Conduct territory specific disease, pathway and medical expert mapping
• >75% of time spent on HCP interactions, HCP focused activities and/or in-field activities
• Establish collaborative relationships with key opinion leaders, prominent academic and clinical investigators and leaders of medical and scientific organisations who can contribute to the clinical diagnosis and management of rare disorders.
• Deliver peer level presentations to HCPs including in-services and group meetings
• Identify and communicate key clinical and research insights from key opinion leaders to help formulate Sobi research and development, and business strategies.
• Respond verbally or by providing appropriate written material to unsolicited requests for on or off label medical information requests and adhere to all company policies and procedures
• Ensure good reporting and interactions with Medical colleagues from other affiliates; share and receive best practices 
• Respond and support unsolicited requests for investigator-initiated studies (IISs)
• Sobi’s expanding portfolio frequently requires targeted project work to determine registration and reimbursement pathways which often demands a high degree of experience, autonomy, and an agile approach.
• Ensure timely and accurate reporting regarding compliance and safety documentation
• Sobi Australia operate as an integrated cross-functional customer-facing team. This role is expected to fulfil the medical affairs components of that engagement and will provide appropriate support to cross functional team members and projects.

• Relevant advanced qualifications in medical science, clinical medicine, or pharmacy. Prior experience in scientific/clinical research or clinical practice would be advantageous.
• Ideally 2 years related pharma/biotech experience including at least 1 year as an MSL or in a medical field role.
• Demonstrated understanding of the drug development and reimbursement process
• Australian Permanent Residency (or equivalent) is a requirement
• Full Australian drivers’ licence
• Completed Medicines Australia CEP program

Desired capabilities

• Medical field competency and capabilities
• Ability to travel at least 50% of time
• Passion for science and teaching
• Adaptable mindset and problem-solving skills
• Excellent oral presentation and written communication skills
• Ability to analyse and effectively communicate scientific information; respond to inquiries and address needs of key stakeholders
• Ability to initiate and maintain relationships networks internally and externally throughout the medical community
• Demonstrated high level of personal integrity, and emotional intelligence
• Understanding of the legal and regulatory environment
• Disease state knowledge, haematology, immunology or rare diseases is preferred
• Proven ability to work autonomously and independently with time management skills
• Ability to maintain a command of a large amount of scientific information across multiple products
• Strong working knowledge of the relevant codes of practice
• Proficient in MS Office applications and platforms

Be willing to adapt to requirements outside of the normal working hours in-order to collaborate with European colleagues.

The MSL is expected to show leadership in the adoption of the Sobi values:

• Care:                       Act in the best interests of patients, colleagues and company
• Ambition:              Stay hungry and challenge the status quo            
• Urgency:                Act now because the patients can't wait and the market won't     
• Ownership:           Take decisions and act on them                               
• Partnership:          Work together so we all win